Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Canopy, based in Smiths Falls, Ont., produces and sells medical cannabis and cannabinoid-based consumer products in Canada ...

Canopy Growth reported improved financial results for Q2, with higher revenue and improved net loss. Find out why CGC stock ...

Canopy Growth’s latest results showcased stronger execution and renewed momentum across key markets. Is CGC stock finally ...

Canopy Growth has expanded its Spectrum Therapeutics portfolio in Australia by introducing new softgel capsules, enhancing its medical cannabis offerings in the region. This expansion strengthens ...

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your ...

Q2 2026 Earnings Call Transcript November 7, 2025 Canopy Growth Corporation beats earnings expectations. Reported EPS is ...

Aurora Cannabis reports Q2-2026 revenue growth with stronger international sales but posts net loss and negative free cash flow. Learn why ACB stock is a hold.

Detailed price information for Canopy Growth Corp (CGC-Q) from The Globe and Mail including charting and trades.

Detailed price information for Canopy Growth Corp (CGC-Q) from The Globe and Mail including charting and trades.

As of Friday, November 07, Ginkgo Bioworks Holdings, Inc.’s DNA share price has dipped by 18.62%, which has investors ...

Topaz Energy is a low-risk royalty and infrastructure play delivering steady, inflation-linked dividends and exceptional free ...